Article | April 17, 2026

The Integration Imperative: Advancing TIDES Manufacturing Through Biocatalysis And Flow Technologies

Source: Asymchem
GettyImages-861606270-lab-development-biologics-mask

Biocatalysis and continuous flow have reshaped small‑molecule manufacturing, but fragmented access to these capabilities continues to slow progress as complexity increases. An integrated manufacturing mindset is emerging as the next critical step — one that unites enzyme engineering, process development, reactor design, and downstream operations into a single, scalable system.

This approach is proving especially transformative for TIDES manufacturing. By combining immobilized enzymes with continuous processing, manufacturers are achieving higher conversions, longer enzyme lifetimes, and meaningful reductions in cost of goods. The same integrated thinking is now extending downstream, where continuous cleavage, deprotection, precipitation, and advanced chromatography are shortening cycle times, improving yields, and reducing solvent use.

Chemoenzymatic synthesis further highlights the value of integration, replacing trial‑and‑error workflows with data‑driven design and streamlined purification strategies that dramatically improve sustainability metrics. Together, these advances point to a future where manufacturing is no longer a series of disconnected steps, but a cohesive system built for scale, reliability, and speed.

Explore how integration is becoming essential as TIDES modalities grow more complex.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Outsourced Pharma